EcoR1 Capital, LLC - Jan 9, 2023 Form 4 Insider Report for Voyager Therapeutics, Inc. (VYGR)

Role
10%+ Owner
Signature
Oleg Nodelman, Manager of EcoR1 Capital, LLC
Stock symbol
VYGR
Transactions as of
Jan 9, 2023
Transactions value $
-$7,142,343
Form type
4
Date filed
1/11/2023, 05:26 PM
Previous filing
Jan 6, 2023
Next filing
Jan 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYGR Common Stock Sale -$3.5M -456K -9.59% $7.67 4.3M Jan 9, 2023 See Note 1 F1, F2, F3
transaction VYGR Common Stock Sale -$2.71M -336K -7.83% $8.05 3.96M Jan 10, 2023 See Note 1 F1, F4, F5
transaction VYGR Common Stock Sale -$935K -110K -2.78% $8.50 3.85M Jan 11, 2023 See Note 1 F1, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

EcoR1 Capital, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds, and Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests the
F2 Qualified Fund sold 429,505 shares of the Common Stock sold in this transaction.
F3 After this transaction, Qualified Fund directly owned 3,999,933 shares of Common Stock.
F4 Qualified Fund sold 268,985 shares of the Common Stock sold in this transaction.
F5 After this transaction, Qualified Fund directly owned 3,730,948 shares of Common Stock.
F6 Qualified Fund sold 103,609 shares of the Common Stock sold in this transaction.
F7 After this transaction, Qualified Fund directly owned 3,627,339 shares of Common Stock.